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ABSTRACT 
The purpose of this research was to develop a novel gastroretentive drug delivery system based on controlled delivery of active agent. 
Tropisetron is an indole derivative having the antiemetic activity. It’s a selective serotonin receptor antagonist. Tropisetron blocks the action 
of serotonin at 5HT3 receptors. It also results in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting. The 
incorporation of swellable and natural polymer for binding action and also good water solublility with high molecular  weight such as carbopol 
present it in the gastro retentive floating tablets, which are designed to provide the desired controlled and complete release of drug for 
prolonged period of time. Lactose was used as filler. Buoyancy was achieved by adding an effervescent mixture of sodium bicarbonate and 
anhydrous citric acid. Floating tablets were prepared by direct compression method. All the required evaluation parameters such as hardness, 
friability, drug content uniformity and swelling index were performed and found within the acceptance limit.  The optimized formulation (F7) 
exhibited 63.87% drug release in 12 hrs emerged as best formulation based on drug release characteristics.  
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INTRODUCTION 
Floating systems tells that the system which are having low 
density having a greater property to buoyancy to float over 
the gastric fluids present in stomach and help in maintaining 
of longer action.[1] When this system floats on the gastric 
contents present in stomach the drug get release in constant 
manner and help to provide a better result and decrease in 
plasma fluctuation.[2] The category of drugs which are poses 
short biological half-life, they can be sustained by floating 
drug delivery system and there efficacy could be increased 
and help in decreasing the dosing frequency .This feature of 
feds is helping in a way to enhance the patient compliance 
and improve the therapy of drug . The fluctuations or no 
constant ratio in drug plasma concentration in plasma are 
minimized or maintained in constant and thus lead to release 
its drug contain in constant manner and help in its efficacy.[3] 
The need of prolonged gastric retention is to improve 
bioavailability of drug, reduces drug waste in stomach, and 
improves solubility of drugs that are having less soluble in a 
high pH in the environment of the stomach.[4] The vital need 
of gastro retention is to help with the better therapeutic 
value of the formulation for the patients and help in 
sustained drug release profile . 
Objective  
The purpose of modification of the gastrointestinal transit 
time of a drug delivery system through floating drug delivery 
system (FDDS),  for providing gastrointestinal absorption of 
drugs for longer period of time and also at site specific 
delivery. 
MATERIALS AND METHOD 
Materials 
Tropisetron, guar gum, Xanthan gum, Carbopol,  sodium 
carbonate, magnesium stearate, citric acid, talc and lactose 
were used. The composition of Floating tablet was 
mentioned in Table 1. 
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Table 1: Composition of floating tablets 
Ingredients F1 F2 F3 F4 F5 F6 F7 
Tropisetron  50 50 50 50 50 50 50 
Guar gum --- 30 40  50 --- --- --- 
Xanthan gum --- --- --- .    --- 30  40  50 
Carbopol 20 20 20 20 20 20 20 
Sodium carbonate 30 30 30 30 30 30 30 
Magnesium stearate 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 
Citric acid 15 15 15 15 15 15 15 
Lactose 75 45 35 25 45 35 25  
 
Method 
Melting point: Melting point was determined by capillary 
method. It was found to be 197-198°c.  
Floating tablets of Tropisetron were prepared by direct 
compression method.  
RESULTS AND DISCUSSION 
Formulation of all the seven batches of floating tablets was 
prepared by changing the concentration of polymers. 
Hardness of tablets was in the range of 3.8- 5 kg/cm2 and 
friability was in the limit of acceptance. Uniformity of weight 
of all the formulations was also within the range. , and 
content uniformity reported Results of pre-compression 
studies were mentioned in Table no.2. Results of post 
compression studies were mentioned in Table no.3 & 4. The 
in vitro drug release of tablets was determined and 
formulation F7 showed least cumulative percentage drug 
release in 60 min. 
 
Table 2: Pre compression parameters 
Formulation Bulk Density G/ml Tapped Density 
G/ml 
Angle of Repose 
Angle 
Carr’s Index Hauser’s Ratio 
F1 0.40 0.39       37 18.21 1.19 
F2 0.37 0.47       25 13.54 1.15 
F3 0.41 0.50       27 14.01 1.08 
F4 0.43 0.51       30 17.04 1.13 
F5 0.39 0.47       26 12.44 1.18 
F6 0.41 0.54    39 14.85 1.15 
F7 0.47 0.57    33 17.98 1.17 
 
Table 3: Post compression parameters 
Formulation Hardness(kg/cm
2 ) 
Thickness (mm) Friability 
% 
Wt. Variation Lag time 
(second) 
Drug 
content 
Floating Time 
(hr.) 
F1 3.8 3.1 0.71 510 52 97.23 10-11 
F2 4.0 3.1 0.91 524 53 98.10 15-16 
F3 3.9 3.4 0.78 494 69 94.35 18-19 
F4 4.2 3.5 0.86 506 71 96.52 19-20 
F5 3.8 3.3 0.80 516 56 99.11 16-17 
F6 4.1 3.6 0.81 502 59 102.4 19-20 
F7 5.0 3.8 0.53 518 82 98.54 18-19 
 
Table 4: In vitro drug release study 
Time ( Hr. ) F1 %CDR F2 %CDR F3 %CDR F4 %CDR F5 %CDR F6% 
CDR 
F7 
%CDR 
1 18.90 8.31 7.01 6.5 7.89 6.5 4.23 
2 40.33 15.02 11.22 9.8 11.65 9.91 6.28 
3 51.33 27.02 17.95 14.3 16.13 14.02 10.98 
4 60.28 31.02 21.01 23.2 20.71 17.09 15.97 
5 67.28 37.02 29.24 27.6 28.78 22.55 21.95 
6 78.23 44.34 36.01 35.3 33.48 30.76 28.32 
7 85.61 49.39 43.24 42.68 39.48 37.83 34.63 
8 98.74 52.00 51.52 46.68 49.52 41.79 39.12 
9 - 59.06 58.28 51.56 57.52 49.28 44.66 
10 - 68.12 63.30 57.90 65.84 53.89 50.36 
11 - 72.24 71.63 64.26 70.27 62.53 56.56 
12 - 77.87 76.75 65.82 76.56 67.66 63.87 
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CONCLUSION 
Floating tablets of Tropicetron were successfully prepared. 
From the study, it can be concluded that polymers used in 
different concentrations which provide longer buoyant 
property and prolonged drug release.  
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